All things tend to regress to the mean.
Vaccine-preventable diseases cost the U.S. $9 billion in 2015, mostly because unvaccinated people got sick.
Scientists seek the holy grail for PTSD research: targets in the brain that could respond to drugs.
Will garage gene editing unleash a biological plague? Special Agent Ed You is ready if it does.
Proposal would use gene-editing patents to force scientists to open their labs to scrutiny.
Spark Therapeutics is within striking distance of a landmark green light from the FDA for its treatment for certain forms of blindness.
Modifying a child’s immune system to fight off leukemia can yield dramatic results, but the treatments are dangerous and no one knows if they’re permanent.
A nonprofit is tapping sequencing technology to guide treatment for thousands of patients.
Cattle that can crank out human antibodies are being tested as a first line of defense against infectious diseases.
Nobody agrees on how best to collect data about diseases that threaten human health. That looks set to change.